Rezultati pretrage - Norbert Gattermann

Detaljiziraj rezultate
  1. 1
    Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

    Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload od Norbert Gattermann

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    The Treatment of Secondary Hemochromatosis

    The Treatment of Secondary Hemochromatosis od Norbert Gattermann

    Izdano 2009
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    Iron overload in myelodysplastic syndromes (MDS)

    Iron overload in myelodysplastic syndromes (MDS) od Norbert Gattermann

    Izdano 2017
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  4. 4
    Valproic acid for the treatment of myeloid malignancies

    Valproic acid for the treatment of myeloid malignancies od Andrea Kuendgen, Norbert Gattermann

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Carta
    Spremi u popis
    Spremljeno u:
  5. 5
    Iron overload in MDS—pathophysiology, diagnosis, and complications

    Iron overload in MDS—pathophysiology, diagnosis, and complications od Norbert Gattermann, Eliezer A. Rachmilewitz

    Izdano 2010
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  6. 6
    Myelodysplastic Syndromes

    Myelodysplastic Syndromes od Peter L. Greenberg, Neal S. Young, Norbert Gattermann

    Izdano 2002
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  7. 7
    Myelodysplastic Syndromes

    Myelodysplastic Syndromes od Ulrich Germing, Guido Kobbe, Rainer Haas, Norbert Gattermann

    Izdano 2013
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  8. 8
    The evaluation of iron deficiency and iron overload

    The evaluation of iron deficiency and iron overload od Norbert Gattermann, Martina U. Muckenthaler, Andreas E. Kulozik, Georgia Metzgeroth, Jan Hastka

    Izdano 2021
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  9. 9
    Myelodysplastic Syndromes in Patients Younger Than Age 50

    Myelodysplastic Syndromes in Patients Younger Than Age 50 od Andrea Kuendgen, Corinna Strupp, Manuel Aivado, Barbara Hildebrandt, Rainer Haas, Norbert Gattermann, Ulrich Germing

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia

    Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia od Norbert Gattermann, Stefan Retzlaff, Yanling Wang, Götz Hofhaus, Jürgen J. Heinisch, Carlo Aul, Wolfgang Schneider

    Izdano 1997
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

    High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifia... od Norbert Gattermann, Johan Billiet, Ralf Kronenwett, E. Zipperer, Ulrich Germing, Friedel Nollet, A. Criel, Dominik Selleslag

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Carta
    Spremi u popis
    Spremljeno u:
  12. 12
    Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

    Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid od Andrea Kuendgen, Corinna Strupp, Manuel Aivado, A. Bernhardt, Barbara Hildebrandt, Rainer Haas, Ulrich Germing, Norbert Gattermann

    Izdano 2004
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome od E. Zipperer, D. Pelz, Kathrin Nachtkamp, A. Kuendgen, C. Strupp, Norbert Gattermann, Rainer Haas, Ulrich Germing

    Izdano 2009
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes

    Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes od Sabine Knipp, Barbara Hildebrand, Andrea Kündgen, Aristoteles Giagounidis, Guido Kobbe, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

    Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes od Judith Neukirchen, Sabine Blum, Andrea Kuendgen, Corinna Strupp, Manuel Aivado, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing

    Izdano 2009
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    Chronic myelomonocytic leukemia in the light of the WHO proposals

    Chronic myelomonocytic leukemia in the light of the WHO proposals od Ulrich Germing, C. Strupp, S. Knipp, A. Kuendgen, Aristoteles Giagounidis, B. Hildebrandt, C. Aul, R Haas, Norbert Gattermann, John M. Bennett

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia

    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia od Andrea Kuendgen, Mathias Schmid, Richard F. Schlenk, Sabine Knipp, Barbara Hildebrandt, Christian Steidl, Ulrich Germing, Rainer Haas, Hartmut Döhner, Norbert Gattermann

    Izdano 2005
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes

    Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes od Lewis R. Silverman, Pierre Fenaux, Ghulam J. Mufti, Valeria Santini, Eva Hellström‐Lindberg, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells

    Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells od Ulrich Steidl, Ralf Kronenwett, Ulrich‐Peter Rohr, Roland Fenk, Slawomir Kliszewski, Christian Maercker, Peter Neubert, Manuel Aivado, J. H. Koch, Olga Modlich, Hans Bojar, Norbert Gattermann, Rainer Haas

    Izdano 2002
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients

    High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients od Jeffrey W. Tyner, Heidi S. Erickson, Michael W. Deininger, Stephanie G. Willis, Christopher A. Eide, Ross L. Levine, Michael C. Heinrich, Norbert Gattermann, D. Gary Gilliland, Brian J. Druker, Marc Loriaux

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: